Here’s How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 2.82% on an annualized basis producing…
Stryker, DaVita And These 2 ETFs: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth,
Earnings Scheduled For January 31, 2023
Companies Reporting Before The Bell
• Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter.
Stryker’s Earnings: A Preview
Stryker (NYSE:SYK) is set to give its latest quarterly earnings report on Tuesday, 2023-01-31. Here’s what investors need…
Keybanc Initiates Coverage On Stryker with Sector Weight Rating
Keybanc analyst Matthew Mishan initiates coverage on Stryker (NYSE:SYK) with a Sector Weight rating.
Analyst Boosts Stryker Price On Easing Staffing, Macro Pressures
RBC Capital Markets upgraded Stryker Corporation (NYSE:SYK) from sector Perform to Outperform, with a price target of $284, up from $240, citing…
Expert Ratings for Stryker
Over the past 3 months, 11 analysts have published their opinion on Stryker (NYSE:SYK) stock. These analysts are…
Morgan Stanley Maintains Equal-Weight on Stryker, Raises Price Target to $260
Morgan Stanley analyst Drew Ranieri maintains Stryker (NYSE:SYK) with a Equal-Weight and raises the price target from $220 to $260.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
9 Analysts Have This to Say About Stryker
Within the last quarter, Stryker (NYSE:SYK) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…